Pamela Vig is CHIEF SCIENTIFIC OFFICER of Mirum Pharmaceuticals, Inc.. Currently has a direct ownership of 27,406 shares of MIRM, which is worth approximately $928,515. The most recent transaction as insider was on Jun 24, 2024, when has been sold 30,559 shares (Common Stock) at a price of $34.0 per share, resulting in proceeds of $1,039,006. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 27.4K
4.48% 3M change
10.98% 12M change
Total Value Held $928,515

Pamela Vig Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 24 2024
SELL
Open market or private sale
$1,039,006 $34.0 p/Share
30,559 Reduced 52.72%
27,406 Common Stock
Jun 24 2024
BUY
Exercise of conversion of derivative security
$89,843 $2.94 p/Share
30,559 Added 34.52%
57,965 Common Stock
May 10 2024
BUY
Grant, award, or other acquisition
$1,978 $21.05 p/Share
94 Added 0.34%
27,406 Common Stock
Feb 02 2024
SELL
Open market or private sale
$31,794 $26.19 p/Share
1,214 Reduced 4.06%
28,691 Common Stock
Jan 08 2024
SELL
Open market or private sale
$39,466 $28.03 p/Share
1,408 Reduced 4.5%
29,905 Common Stock
Nov 10 2023
BUY
Grant, award, or other acquisition
$11,746 $22.29 p/Share
527 Added 1.66%
31,313 Common Stock
Jul 03 2023
SELL
Open market or private sale
$36,551 $25.65 p/Share
1,425 Reduced 4.42%
30,786 Common Stock
May 10 2023
BUY
Grant, award, or other acquisition
$11,573 $16.92 p/Share
684 Added 2.08%
32,211 Common Stock
Jan 31 2023
BUY
Grant, award, or other acquisition
-
9,625 Added 23.39%
31,527 Common Stock
Jan 09 2023
SELL
Open market or private sale
$28,434 $20.62 p/Share
1,379 Reduced 4.81%
27,312 Common Stock
Nov 10 2022
BUY
Grant, award, or other acquisition
$11,253 $17.05 p/Share
660 Added 2.93%
21,902 Common Stock
May 10 2022
BUY
Grant, award, or other acquisition
$10,951 $13.57 p/Share
807 Added 3.66%
21,242 Common Stock
Jan 06 2022
BUY
Grant, award, or other acquisition
-
10,000 Added 32.86%
20,435 Common Stock
Nov 10 2021
BUY
Grant, award, or other acquisition
$10,383 $13.52 p/Share
768 Added 6.86%
10,435 Common Stock
Oct 01 2021
SELL
Open market or private sale
$26,271 $19.26 p/Share
1,364 Reduced 12.37%
9,667 Common Stock
Sep 29 2021
BUY
Grant, award, or other acquisition
-
8,125 Added 42.41%
11,031 Common Stock
May 10 2021
BUY
Grant, award, or other acquisition
$10,219 $14.62 p/Share
699 Added 19.39%
2,906 Common Stock
Nov 10 2020
BUY
Grant, award, or other acquisition
$9,086 $15.27 p/Share
595 Added 21.23%
2,207 Common Stock
PV

Pamela Vig

CHIEF SCIENTIFIC OFFICER
Foster City, CA

Track Institutional and Insider Activities on MIRM

Follow Mirum Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MIRM shares.

Notify only if

Insider Trading

Get notified when an Mirum Pharmaceuticals, Inc. insider buys or sells MIRM shares.

Notify only if

News

Receive news related to Mirum Pharmaceuticals, Inc.

Track Activities on MIRM